Cargando…
Impacts of the regulatory environment for gene editing on delivering beneficial products
Various genome-editing technologies have been embraced by plant breeders across the world as promising tools for the improvement of different crops to deliver consumer benefits, improve agronomic performance, and increase sustainability. The uptake of genome-editing technologies in plant breeding gr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376113/ https://www.ncbi.nlm.nih.gov/pubmed/34429575 http://dx.doi.org/10.1007/s11627-021-10201-4 |
_version_ | 1783740439414702080 |
---|---|
author | Jenkins, Daniel Dobert, Raymond Atanassova, Ana Pavely, Chloe |
author_facet | Jenkins, Daniel Dobert, Raymond Atanassova, Ana Pavely, Chloe |
author_sort | Jenkins, Daniel |
collection | PubMed |
description | Various genome-editing technologies have been embraced by plant breeders across the world as promising tools for the improvement of different crops to deliver consumer benefits, improve agronomic performance, and increase sustainability. The uptake of genome-editing technologies in plant breeding greatly depends on how governments regulate its use. Some major agricultural production countries have already developed regulatory approaches that enable the application of genome editing for crop improvement, while other governments are in the early stages of formulating policy. Central to the discussion is the principle of “like products should be treated in like ways” and the subsequent utilization of exclusions and exemptions from the scope of GMO regulations for these products. In some countries, the outcomes of genome editing that could also have been achieved through conventional breeding have been defined as not needing GMO regulatory oversight. In this paper, we provide a short overview of plant breeding and the history of plant biotechnology policy development, the different classes of current regulatory systems and their use of exemptions and exclusions for genome-edited plants, and the potential benefits of such approaches as it relates to achieving societal goals. |
format | Online Article Text |
id | pubmed-8376113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-83761132021-08-20 Impacts of the regulatory environment for gene editing on delivering beneficial products Jenkins, Daniel Dobert, Raymond Atanassova, Ana Pavely, Chloe In Vitro Cell Dev Biol Plant Special Issue on Genome Editing Various genome-editing technologies have been embraced by plant breeders across the world as promising tools for the improvement of different crops to deliver consumer benefits, improve agronomic performance, and increase sustainability. The uptake of genome-editing technologies in plant breeding greatly depends on how governments regulate its use. Some major agricultural production countries have already developed regulatory approaches that enable the application of genome editing for crop improvement, while other governments are in the early stages of formulating policy. Central to the discussion is the principle of “like products should be treated in like ways” and the subsequent utilization of exclusions and exemptions from the scope of GMO regulations for these products. In some countries, the outcomes of genome editing that could also have been achieved through conventional breeding have been defined as not needing GMO regulatory oversight. In this paper, we provide a short overview of plant breeding and the history of plant biotechnology policy development, the different classes of current regulatory systems and their use of exemptions and exclusions for genome-edited plants, and the potential benefits of such approaches as it relates to achieving societal goals. Springer US 2021-08-19 2021 /pmc/articles/PMC8376113/ /pubmed/34429575 http://dx.doi.org/10.1007/s11627-021-10201-4 Text en © The Society for In Vitro Biology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Special Issue on Genome Editing Jenkins, Daniel Dobert, Raymond Atanassova, Ana Pavely, Chloe Impacts of the regulatory environment for gene editing on delivering beneficial products |
title | Impacts of the regulatory environment for gene editing on delivering beneficial products |
title_full | Impacts of the regulatory environment for gene editing on delivering beneficial products |
title_fullStr | Impacts of the regulatory environment for gene editing on delivering beneficial products |
title_full_unstemmed | Impacts of the regulatory environment for gene editing on delivering beneficial products |
title_short | Impacts of the regulatory environment for gene editing on delivering beneficial products |
title_sort | impacts of the regulatory environment for gene editing on delivering beneficial products |
topic | Special Issue on Genome Editing |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376113/ https://www.ncbi.nlm.nih.gov/pubmed/34429575 http://dx.doi.org/10.1007/s11627-021-10201-4 |
work_keys_str_mv | AT jenkinsdaniel impactsoftheregulatoryenvironmentforgeneeditingondeliveringbeneficialproducts AT dobertraymond impactsoftheregulatoryenvironmentforgeneeditingondeliveringbeneficialproducts AT atanassovaana impactsoftheregulatoryenvironmentforgeneeditingondeliveringbeneficialproducts AT pavelychloe impactsoftheregulatoryenvironmentforgeneeditingondeliveringbeneficialproducts |